Takehiko Sasazuki

Takehiko Sasazuki

Auto-generated profile, based on publicly available information

Takehiko Sasazuki

Kyushu University

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2022 in Science Advances
Verified
Journal Article
Open access
HJHui Jin
Hui Jin
KKKazuki Kishida
Kazuki Kishida
NANoriko Arase
Noriko Arase
SMSumiko Matsuoka
Sumiko Matsuoka
WNWataru Nakai
Wataru Nakai
HAHisashi Arase
Hisashi Arase
Specific MHC class II alleles are strongly associated with susceptibility to various autoimmune diseases. Although the primary function of MHC class II molecules is to present peptides to helper T cells, MHC class II molecules also function like a chaperone to transport misfolded intracellular proteins to the cell surface. In this study, we found that autoantibodies in patients with Graves’ disease preferentially recognize thyroid-stimulating hormone receptor (TSHR) complexed with MHC class II molecules of Graves’ disease risk alleles, suggesting that the aberrant TSHR transported by MHC class II molecules is the target of autoantibodies produced in Graves’ disease. Mice injected with cells expressing mouse TSHR complexed with MHC class II molecules, but not TSHR alone, produced anti-TSHR autoantibodies. These findings suggested that aberrant self-antigens transported by MHC class II molecules exhibit antigenic properties that differ from normal self-antigens and abrogate self-tolerance, providing a novel mechanism for autoimmunity.

1 August 1996 in Acta Paediatrica
Verified
Journal Article
Closed access
PDF file
KMKazuhiro Mori
Kazuhiro Mori
TST Sasazuki
T Sasazuki
AKAkinori Kimura
Akinori Kimura
YIY Ito
Y Ito

1 August 1992 in Immunogenetics
Verified
Journal Article
Closed access
PDF file
SSSatoru Senju
Satoru Senju
AKAkinori Kimura
Akinori Kimura
MYMichio Yasunami
Michio Yasunami
NKNobuhiro Kamikawaji
Nobuhiro Kamikawaji
HYHideyuki Yoshizumi
Hideyuki Yoshizumi
TSTakehiko Sasazuki
Takehiko Sasazuki

1 June 1992 in Immunogenetics
Verified
Journal Article
Closed access
PDF file
RDRui-Ping Dong
Rui-Ping Dong
AKAkinori Kimura
Akinori Kimura
TSTakehiko Sasazuki
Takehiko Sasazuki

20 October 2004 in Tissue Antigens
Verified
Journal Article
Open access
PDF file
SSS. Shichijo
S. Shichijo
NKNaoto Keicho
Naoto Keicho
HLH.T. Long
H.T. Long
TQT. Quy
T. Quy
NPN.C. Phi
N.C. Phi
TST. Sasazuki
T. Sasazuki
Abstract:  In order to determine highly immunogenic severe acute respiratory syndrome coronavirus (SARS‐CoV) epitope peptides capable of inducing long‐lasting immunity, we first screened immunoglobulin‐G (IgG) antibodies reactive to 197 different overlapping 15‐mers from the SARS‐CoV proteins in the sera of three infected patients. Forty‐two peptides among them were reactive to the sera from all three patients. Consequently, we tested for the reactivity of these 42 peptides to patients' sera (n = 45) at 6‐month post‐infection. The significantly higher levels of IgG antibodies specific to three (S791, M207 and N161) of 42 peptides were detectable in the post‐infection sera from 23 (51%), 27 (60%) and 19 (42%) of 45 patients, respectively. These three peptides, recognized by their long‐lasting immunity, may provide a better understanding of the immunogenicity of SARS‐CoV.

1 November 1998 in Protein Engineering, Design and Selection
Verified
Journal Article
Open access
PDF file
HTH. Toh
H. Toh
NKN. Kamikawaji
N. Kamikawaji
TTT. Tana
T. Tana
TST. Sasazuki
T. Sasazuki
SKS. Kuhara
S. Kuhara
The specific recognition of foreign peptide bound to the major histocompatibility complex (MHC) molecule by T-cell receptor (TCR) leads to T-cell activation. We found that analogue peptides containing single amino acid substitutions at the third amino acid position (p3), p5, p7 and p8 of the index peptide (YWALEAAAD) induced different response patterns of T cell clones specific for the index peptide in the context of the human MHC class II molecule HLA-DR4. Analogue peptides were classified into three types, agonists, antagonists or null peptides (non-agonistic and non-antagonistic peptides). A molecular basis for how these slight changes lead to such different consequences for T cells has not been described. To explore the mechanistic basis of these observations, molecular dynamics simulations at 300 K of 300 ps duration were carried out for the DR4-index peptide, DR4-agonist, and DR4-antagonist complexes. The simulations showed that the DR4-antagonist complexes were distinguished from the DR4-index peptide and DR4-agonist complexes by relatively higher deviations of C(alpha) atoms in proposed TCR-binding regions, suggesting that subtle changes of the exposed framework of the peptide binding groove by the antagonist peptides could induce the TCR antagonistic activities.